N/A
N=30
Wear Experience With Daily Toric Contact Lenses Over a Long Day
Contact Lens · Astigmatism of Both Eyes
Bottom Line
View on ClinicalTrials.gov: NCT04844281 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Subjective Vision in Contact Lenses Assessed Using a 1 to 10 Scale After 16 Hours of Wear in One Day (After up to 14 Days of Wear) — 9 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Precision1® Daily Disposable Toric Contact Lens (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Ohio State University
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Vision in Contact Lenses Assessed Using a 1 to 10 Scale After 16 Hours of Wear in One Day (After up to 14 Days of Wear) |
9 | — |
| PRIMARY Subjective Comfort on a 1-10 Scale After 16 Hours of Wear in One Day (After up to 14 Days of Wear) |
8.4 | — |
Summary
This study is evaluating the wear experience of a daily toric contact lens after 10, 12, 14, and 16 hours of lens wear.
Eligibility Criteria
Inclusion Criteria
- Must be current soft toric contact lens wearers with longs days of lens wear within the parameters of Precision1® lenses available.
- Distance visual acuity of 20/25 or better with current lenses.
- Recent eye exam in the last year.
- Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
- Ability to give informed consent.
- Must have a working smart phone or device and be willing to receive and respond to texts and/or emails.
- Willing to spend time for the study, which includes three in-person study visits (with a possible fourth visit if needed), wearing contact lenses on days between study visits, and responding to communications on a smart phone or other electronic device on five weekdays between Visits 2 and 3.
Exclusion Criteria
- Current ocular inflammation or infection as assessed by the study investigator.
- Currently pregnant, lactating, or planning to become pregnant during the course of the study.
Data sourced from ClinicalTrials.gov (NCT04844281). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.